Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Shares Outstanding (2022 - 2025)

Envoy Medical's Shares Outstanding history spans 4 years, with the latest figure at $4.1 million for Q3 2025.

  • For Q3 2025, Shares Outstanding fell 8.3% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $4.1 million, down 8.3%, while the annual FY2024 figure was $21.3 million, 373.92% up from the prior year.
  • Shares Outstanding for Q3 2025 was $4.1 million at Envoy Medical, roughly flat from $4.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $21.3 million in Q4 2024 and bottomed at $4.1 million in Q2 2025.
  • The 4-year median for Shares Outstanding is $10.1 million (2022), against an average of $12.9 million.
  • The largest annual shift saw Shares Outstanding tumbled 55.55% in 2023 before it skyrocketed 373.92% in 2024.
  • A 4-year view of Shares Outstanding shows it stood at $10.1 million in 2022, then crashed by 55.54% to $4.5 million in 2023, then surged by 373.92% to $21.3 million in 2024, then crashed by 80.65% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Shares Outstanding are $4.1 million (Q3 2025), $21.5 million (Q2 2025), and $21.3 million (Q1 2025).